PLIANT THERAPEUTICS, INC.
PLIANT THERAPEUTICS, INC. (PLRX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 182 transactions totaling $23.9M, demonstrating a bearish sentiment with -$23.9M in net insider flow. The most recent transaction on Jan 22, 2026 involved a transaction of 1,230,000 shares valued at $0.
PLRX Insider Activity Summary
Who Is Buying PLRX Stock?
No significant insider buying has been recorded for PLRX in the recent period.
Who Is Selling PLRX Stock?
No significant insider selling has been recorded for PLRX in the recent period.
Is PLIANT THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PLRX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$23.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PLRX Frequently Asked Questions
Understanding PLRX Insider Activity
Insider trading at PLIANT THERAPEUTICS, INC. (PLRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading PLRX stock, having executed 182 transactions in the past 90 days. The most active insider is Bernard Coulie (Executive), who has made 79 transactions totaling $13.8M.
Related Tools
Track PLIANT THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at PLRX file new Form 4 transactions